GONELLA JACQUES 4
4 · ANTARES PHARMA, INC. · Filed May 18, 2018
Insider Transaction Report
Form 4
GONELLA JACQUES
Director10% Owner
Transactions
- Sale
Common Stock
2018-05-16$2.52/sh−100,000$252,000→ 11,286,413 total - Sale
Common Stock
2018-05-17$2.55/sh−100,000$255,000→ 11,186,413 total
Footnotes (1)
- [F1]The sale of common stock reported in this Form 4 was made for estate planning purposes.